Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis

Exclusion Criteria

• •Receipt of investigational medication within 4 weeks prior to participation in the study
• •Pregnant or breast-feeding
• •Severe congestive heart failure
• •Known severe HIV infection
• •Presence of severe burns
• •Patients on high dose immunosuppressants
• •Patients whose death is considered imminent
• •Patients whose life expectancy for concurrent illness is less than 6 months
• •Severe hypoxic encephalopathy or persistent vegetative state
• •Severe liver disease
• •Chronically bed bound
• •Patient, legal representative or patient's primary physician not committed to providing full, aggressive life support